Stocklytics Platform
Asset logo for symbol USNA
USANA Health Sciences
USNA58
$29.14arrow_drop_down4.05%-$1.23
Asset logo for symbol USNA
USNA58

$29.14

arrow_drop_down4.05%
Key Stats
Open$30.62
Prev. Close$30.37
EPS2.19
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range28.68
32.26
52 Week Range27.77
59.85
Ratios
Revenue-
EPS2.19
Fundamentals
Payout Ratio-
Industry average yield2.92%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

USNA-
US Consumer Defensive Sector-
US Market-
warning

USNA / Market

USNA lose to the US Market which returned 2.09% over the last twenty four hours.
warning

USNA / Consumer Defensive Sector

USNA lose to the US Consumer Defensive sector which returned 1.76% over the last twenty four hours.

USANA Health Sciences (USNA) Statistics

USANA Health Sciences Inc (USNA) is a global nutritional company that develops, manufactures, and sells high-quality dietary supplements, personal care, and weight management products. With a focus on science-based nutrition and a commitment to excellence, USANA has built a solid reputation in the health and wellness industry. The company operates in numerous markets worldwide, offering its products through a direct selling model. As a publicly traded company, USANA’s stock is listed on the New York Stock Exchange under the ticker symbol USNA.
When it comes to stock statistics, USANA has displayed strong performance over the years. The stock has shown resilience in various market conditions and has generated solid returns for investors. As of the most recent data, USANA's stock has a market capitalization of several billion dollars, reflecting the company's substantial size and value. In terms of valuation metrics, USANA's stock is attractively priced compared to its peers in the industry. The company's price-to-earnings ratio, which measures the stock's valuation relative to its earnings, is favorable compared to the industry average. This indicates that USANA's stock may be undervalued and presents an opportunity for potential investors.
add USANA Health Sciences  to watchlist

Keep an eye on USANA Health Sciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has USANA Health Sciences (USNA) stock's performance compared to its sector and the market over the past year?

Over the past year, USANA Health Sciences (USNA) has experienced a price change of . Compared to the Consumer Defensive sector, which saw a change of 21.28%, USANA Health Sciences has underperformed compared to its sector, indicating its relative standing within the Consumer Defensive sector. Against the broader market's change of 4.89%, it has fallen short of the market average. This comparison highlights USANA Health Sciences 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of USANA Health Sciences (USNA) stock?

The PE (Price to Earnings) ratio of USANA Health Sciences (USNA) is currently 13.31. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of USANA Health Sciences (USNA) stock?

The Earnings Per Share (EPS) for USANA Health Sciences (USNA), calculated on a diluted basis, is $2.19. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of USANA Health Sciences (USNA) stock?

The operating margin for USANA Health Sciences (USNA) is 7.7%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of USANA Health Sciences (USNA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of USANA Health Sciences (USNA) is $114.05M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does USANA Health Sciences (USNA) have?

USANA Health Sciences (USNA) has a total debt of $23M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$364.89M.

Take Your Investments to a Whole New Level